WACKER CHEMIE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.3 EUR | -1.52% |
|
-8.53% | -12.25% |
| 26/04 | WACKER CHEMIE AG : Berenberg reiterates its Neutral rating | ZD |
| 25/04 | Wacker Chemie still cautious - analyst: light and shade in the quarter | DP |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -12.25% | 5.32B | A- | ||
| -1.62% | 19.88B | - | ||
| +1.89% | 1.32B | B | ||
| -5.86% | 1.14B | B- | ||
| +25.19% | 996M | - | ||
| -22.65% | 688M | - | ||
| -14.91% | 674M | - | - | |
| -17.53% | 277M | - | - | |
| -1.84% | 260M | D- | ||
| -12.55% | 253M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- WCH Stock
- Ratings Wacker Chemie AG
